Role of maintenance oral dexamethasone in prophylaxis of delayed emesis caused by moderately emetogenic chemotherapy

Annals of Oncology

Volumn 7, Issue 1, 1996, Pages 71-74

  Koo, W H ^a   Ang, P T ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Cyclophosphamide; Delayed emesis; Dexamethasone; Granisetron

Indexed keywords

CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; GRANISETRON; METHOTREXATE; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CONSTIPATION; CONTROLLED STUDY; FEMALE; HEADACHE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; VOMITING;

EID: 0030034135     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.annonc.a010483     Document Type: Article

References (28)

1. Soukop M. McQuade B, Hunter E et al. Ondansetron compared with metoclopramide in the control of emesis and quality of life during repeated chemotherapy for breast cancer. Oncology 1992; 49: 295-304.
2. Clavel M, Soukop M, Greenstreet YLA. Improved control of emesis and quality of life with ondansetron in breast cancer. Oncology 1993; 50: 180-5.
3. Laszlo J. Emesis as limiting toxicity in cancer chemotherapy. In Laszlo J (ed): Antiemetics and Cancer Chemotherapy. Baltimore: Williams & Wilkins 1983; 1-5.
4. Bonneterre J, Chevallier B, Metz R et al. A randomized double-blind comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cyclophosphamide, fluorouracil, and doxorubicin or epirubicin chemotherapy. J Clin Oncol 1990; 8: 1063-9.
5. Schmoll HJ. The role of ondansetron in the treatment of emesis induced by non-cisplatin containing chemotherapy. Eur J Cancer Clin Oncol 1989; 25(Suppl 1): 535-9.
6. Marty M, Pouillart P, Scholl S et al. Comparison of the 5-hydroxytryptamine3 (serotonin) antagonist ondansetron (GR38032F) with high-dose metoclopramide in control of cisplatin-induced emesis. N Engl J Med 1990; 322: 816-21.
7. Kris MG, Gralla RJ, Clark R et al. Incidence, course and severity of delayed nausea and vomiting following administration of high dose cisplatin. J Clin Oncol 1985; 3: 1397-404.
8. Mason BA, Dambra J, Grossman B et al. Effective control of cisplatin-induced nausea using high-dose steroids and droperidol. Cancer Treat Rep 1985; 66: 243-5.
9. Roila F, Tonato M, Cognetti F et al. Prevention of cisplatin-induced emesis: A double-blind multicenter randomized crossover study comparing ondansetron and ondansetron plus dexamethasone. J Clin Oncol 1991; 9: 675-8.
10. Kris MG, Gralla RJ, Tyson LB et al. Controlling delayed vomiting: Double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin. J Clin Oncol 1989; 7: 108-14.
11. Marty M on behalf of the Granisetron Study Group. A comparison of granisetron as a single agent with conventional antiemetic therapies in the treatment of cytostatic-induced emesis. Eur J Cancer 1992; 28A (Suppl 1): S12-6.
12. Jantunen IT, Muhonen TT, Kataja W et al. 5-HT3 receptor antagonists in the prophylaxis of acute vomiting induced by moderately emetogenic chemotherapy - a randomised study. Eur J Cancer 1993; 29A 12:1669-72.
13. Fetting JH, Grochow LB. Folstein MF et al. The course of nausea and vomiting after high-dose cyclophosphamide. Cancer Treat Rep 1982; 66: 1487-93.
14. Cubeddu LX, Hoffman IS, Fuenmayor NT et al. Antagonism of serotonin S3 receptors with ondansetron prevents nausea and emesis induced by cyclophosphamide-containing chemotherapy regimens. J Clin Oncol 1990; 8: 1721-7.
15. Lindley CM, Bernard S, Fields SM. Incidence and duration of chemotherapy induced nausea and vomiting in the outpatient oncology population. J Clin Oncol 1989; 7: 1142-9.
16. Bleiberg H. Antiemetic agents. Curr Opin Oncol 1992; 4: 597-604.
17. Hoagland AC, Morrow GR, Bennett JM, Carnrike CLM Jr. Oncologists' views of cancer patient noncompliance. Am J Clin Oncol 1983; 6: 239-44.
18. Rich WM, Abdulhayoglu G, Disaia PJ. Methylprednisolone as an antiemetic during cancer chemotherapy - a pilot study. Gynecol Oncol 1980; 9: 193-8.
19. Baker JJ, Lokey JL, Price NA et al. Comparison of dexamethasone plus prochlorperazine to placebo with prochlorperazine as antiemetic for cancer chemotherapy. Proc Am Assoc Cancer Res Am Soc Clin Oncol 1981; 21: 339 (Abstr).
20. Drapkin RL, Sokol GH, Paladine WJ et al. The antiemetic effect and dose response of dexamethasone in patients receiving cisplatinum. Proc Am Soc Clin Oncol 1982; 1: 61 (Abstr).
21. Cassileth PA, Lusk EJ, Torri S et al. Antiemetic efficacy of dexamethasone therapy in patients receiving cancer chemotherapy. Arch Intern Med 1983; 143: 1347-9.
22. Markman M, Sheidler V, Ettinger DS et al. Antiemetic efficacy of dexamethasone. Randomized, double-blind, crossover study with prochlorperazine in patients receiving cancer chemotherapy. N Engl J Med 1984; 311: 549-52.
23. Aapro MS, Plezia PM, Alberts DS et al. Double-blind crossover study of the antiemetic efficacy of high-dose dexamethasone vs. high-dose metoclopramide. Proc Am Soc Clin Oncol 1983; 2: 93 (Abstr).
24. Jones AJL, Hill AS, Soukop M et al. Comparison of dexamethasone and ondansetron in the prophylaxis of emesis induced by moderately emetogenic chemotherapy. Lancet 1991; 338: 483-7.
25. Joss RA, Bacchi M, Buser K et al. for the Swiss Group for Clinical Cancer Research (SAKK). Ondansetron plus dexamethasone is superior to ondansetron alone in the prevention of emesis in chemotherapy-naive and previously treated patients Ann Oncol 1994; 5: 253-8.
26. Smith DB, Newlands ES, Rustin GJ et al. Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy. Lancet 1991; 338: 487-90.
27. Smyth JF, Coleman RE, Nicolson M et al. Does dexamethasone enhance control of acute cisplatin induced emesis by ondansetron? Br Med J 1991; 303: 1423-6.
28. Cunningham D, Evans C, Gazet J et al. Comparison of antiemetic efficacy of domperidone, metoclopramide, and dexamethasone in patients receiving outpatient chemotherapy regimens. Br Med J 1987; 295: 250.